Stem Holdings Inc. Hires Former Sales Executive from Nike’s Jordan Brand, Eugene (Geno) Purtell, as Oregon Director of Sale...
November 02 2018 - 9:00AM
Stem Holdings, Inc. (OTCQB: STMH CSE: STEM) (the Company or Stem),
is excited to announce the hiring of Geno Purtell to serve as
Stem’s Oregon Director of Sales. As a former Nike executive, Geno
brings over 20 years of extensive sales experience to Stem and is
looking forward to making the transition into the cannabis
industry. Before leaving Nike in 2017, Geno worked as a Strategic
Sales Rep, a Product Line Sales Manager, the European Divisional
Sales Manager in Amsterdam, as well as the Strategic Account
Director for New York City. Most recently, Mr. Purtell was the
Jordan Brand Sales Director for strategic accounts.
“I can’t tell you how excited I am to
be part of this burgeoning industry,” says Geno. “I have over 30
years of strategic selling experience to share with Stem, and I
know my expertise will help Stem’s brands increase sales throughout
Oregon.
Geno will work with both TJ’s Gardens and Yerba
Buena with the goal to build a robust sales initiative for both
brands’ products. In addition, he will be tasked with helping to
sell incredibles’ products, Cannavore caramels, G Pen vaporizers,
and Tinctures by TJ’s throughout the State of Oregon.
“We couldn’t be more thrilled to have Geno join
our team,” says Geoff Ostrove, National Director of Business
Development for Stem. “We believe that his skills and experience
will be extremely valuable as Stem continues to grow their brand
market share within the Oregon cannabis industry.”
With the addition of Geno Purtell, as well as
the recent acquisition of Yerba Buena, Stem continues to position
itself as one of the leading cannabis companies in Oregon.
“We will be leaders in this industry and we will
continue to stay focused on healthy, profitable, and sustainable
growth for Stem’s brands and retail partners,” says Geno. “As
Abraham Lincoln once said, ‘The best way to predict the future is
to create it’ and at Stem, our plan is to do just that - to help
create the future by only selling the highest-quality products in
the cannabis industry.”
About Stem Holdings Inc.
Stem has positioned itself as a leader in the
U.S. cannabis industry by building and operating state-of-the-art
cannabis licensed solutions that include: cultivation, processing
and retail properties across multiple U.S. markets. As one of the
most innovative cannabis companies, Stem operates, acquires and
improves properties for cannabis industry operators and provides
turn-key vertically integrated solutions including but not limited
to marijuana and hemp cultivation, extraction, infused products and
processing. These cannabis entities have developed an extensive
portfolio of award-winning consumer-facing brands such as TJ’s
Gardens, Yerba Buena®, Cannavore®, incredibles®, Dose-ology and
Green T-Farms. For more information,
visit www.stemholdings.com.
Cautionary Note Regarding Forward-Looking
Information
This press release contains statements which
constitute “forward-looking information” within the meaning of
applicable securities laws, including statements regarding the
plans, intentions, beliefs and current expectations of the
management of Stem with respect to future business activities.
Forward-looking information is often identified by the words “may”,
“would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”,
“believe”, “estimate”, “expect” or similar expressions and include
information regarding: (i) the ability of the Company to
successfully achieve its business objectives, (ii) plans for
expansion of Stem, (iii) expectations for other economic, business,
and/or competitive factors, and plans to grow Stem’s market share
in the State of Oregon and nationally.
Investors are cautioned that forward-looking
information is not based on historical facts but instead reflect
the management of Stem’s expectations, estimates or projections
concerning future results or events based on the opinions,
assumptions and estimates of management considered reasonable at
the date the statements are made. Although Stem believes that the
expectations reflected in such forward-looking information are
reasonable, such information involves risks and uncertainties, and
undue reliance should not be placed on such information, as unknown
or unpredictable factors could have material adverse effects on
future results, performance or achievements of the Company. Among
the key factors that could cause actual results to differ
materially from those projected in the forward-looking information
are the following: changes in general economic, business and
political conditions, including changes in the financial markets;
and in particular in the ability of the Company to raise debt and
equity capital in the amounts and at the costs that it expects;
adverse changes in the public perception of cannabis; decreases in
the prevailing prices for cannabis and cannabis products in the
markets that the Company operates in; adverse changes in applicable
laws; or adverse changes in the application or enforcement of
current laws, including those related to taxation; the inability to
locate and acquire suitable companies, properties and assets
necessary to execute on the Company’s business plans; and
increasing costs of compliance with extensive government
regulation. This forward-looking information may be affected by
risks and uncertainties in the business of Stem and market
conditions.
Should one or more of these risks or
uncertainties materialize, or should assumptions underlying the
forward-looking information prove incorrect, actual results may
vary materially from those described herein as intended, planned,
anticipated, believed, estimated or expected. Although Stem has
attempted to identify important risks, uncertainties and factors
which could cause actual results to differ materially, there may be
others that cause results not to be as anticipated, estimated or
intended. Stem does not intend, and does not assume any obligation,
to update this forward-looking information except as otherwise
required by applicable law.
No securities regulatory authority has in any
way passed upon the merits of the proposed transactions described
in this news release or has approved or disapproved of the contents
of this news release.
For further information, please contact:
Investor Relations Contact:Amato and Partners,
LLCInvestor Relations
Counsel212.460.0360admin@amatopartners.com
Media Contact:Mauria BettsDirector of Branding
and Public Relations(971) 266-1908mauria@stemholdings.com
Microbot Medical (NASDAQ:MBOT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Microbot Medical (NASDAQ:MBOT)
Historical Stock Chart
From Sep 2023 to Sep 2024